. Increased of Baht 3.40 Million, from same period of last year. Due to the Group has profit from selling scrap and unused construction machine, equiptment, and consumable during the year.   Moreover, during

because of the following; - Decreased in gain on foreign exchange rate from Q1’19 amounting of 1.53 Million Baht and gain on selling of scrap and unused construction machine equipment and consumable

labor, tool and consumable, including hygiene products used for preventing the spread of coronavirus. Q2/2020, the Group’s has net profit attributable to owners of the parent totaling of Baht 13.49

The Group’s other revenue of Q3/2019 totaling of Baht 2.29 Million. Increased from same period of last year, because of the Group has profit from selling scrap and unused construction consumable. 3

Government. According to the increased of the market competition both of the competitor and the pricing, some project could not continue to extend the services. 2.2 Revenue from Contact Center Facility

Bt798.65mn, decreasing 5.2% YoY and 2.5% QoQ. The YoY decreased was mainly from declining in mobile top up value which the result of 3 factors: The competitor, the campaign “prepaid to postpaid” of mobile

products that has not yet the competitor. And has been researching and good testing. 4. Details of acquired assets Details of the BS Myco Biotech Company Limited as follows: 4.1 General information

increased use of autoclaved aerated concrete blocks as Thailand follows a global trend. The nonferrous mining segment in our key export market Laos remains strong however as a new competitor comes on stream

high performance paints. The proceeds from the capital increase will be used for the Company's core business. In addition, the IGE's business is not a competitor to its major shareholders. As the major

testing of quality and market capability. However, the rapid change of battery technology nowadays plus the numbers of new competitor in the market, highly priced-competitive environment, may slow down the